Product NDC: | 55390-029 |
Proprietary Name: | Famotidine |
Non Proprietary Name: | Famotidine |
Active Ingredient(s): | 10 mg/mL & nbsp; Famotidine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-029 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075622 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010416 |
Package NDC: | 55390-029-10 |
Package Description: | 10 VIAL in 1 BOX (55390-029-10) > 2 mL in 1 VIAL |
NDC Code | 55390-029-10 |
Proprietary Name | Famotidine |
Package Description | 10 VIAL in 1 BOX (55390-029-10) > 2 mL in 1 VIAL |
Product NDC | 55390-029 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Famotidine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010416 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | FAMOTIDINE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |